Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Breast Cancer Research : BCR|April 19, 2015
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical modelLara Lacerda, Bisrat G Debeb, Daniel Smith, et al.Clinical Lung Cancer|December 4, 2014
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiationCameron W Swanick, Steven H Lin, Jordan Sutton, et al.Journal of the National Medical Association|July 16, 2004
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancerCharles J Rosser, Deborah A Kuban, Sang-Joon Lee, et al.International Journal of Radiation Oncology, Biology, Physics|February 5, 2013
Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancerQingsong Pang, Qingyi Wei, Ting Xu, et al.International Journal of Radiation Oncology, Biology, Physics|May 22, 2012
HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancerTing Xu, Qingyi Wei, Jose Luis Lopez Guerra, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2015
Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancerQuynh-Nhu Nguyen, Ngoc Bui Ly, Ritsuko Komaki, et al.American Journal of Clinical Oncology|April 16, 2014
The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate CancerShelly X Bian, Deborah A Kuban, Lawrence B Levy, et al.Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesotheliomaRenato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.Head & Neck|February 4, 2015
Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapyAndrew J Bishop, Adam S Garden, G Brandon Gunn, et al.Pageof 6